학술논문
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer
Document Type
Clinical report
Author
Posner, Marshall R.; Hershock, Diane M.; Blajman, Cesar R.; Mickiewicz, Elizabeth; Winquist, Eric; Gorbounova, Vera; Tjulandin, Sergei; Shin, Dong M.; Cullen, Kevin; Ervin, Thomas J.; Murphy, Barbara A.; Raez, Luis E.; Cohen, Roger B.; Spaulding, Monica; Tishler, Roy B.; Roth, Berta; Viroglio, Rosana del Carmen; Venkatesan, Varagur; Romanov, Ilya; Agarwala, Sanjiv; Harter, K. William; Dugan, Matthew; Cmelak, Anthony; Markoe, Arnold M.; Read, Paul W.; Steinbrenner, Lynn; Colevas, A. Dimitrios; Norris, Charles M., Jr.; Haddad, Robert I.
Source
The New England Journal of Medicine. Oct 25, 2007, Vol. 357 Issue 17, p1705, 11 p.
Subject
Language
English
ISSN
0028-4793
Abstract
A randomized phase 3 trial results of the treatment of squamous-cell carcinoma of head and neck is presented. Patients receiving docetaxel plus cisplatin and fluorouracil induction chemotherapy plus chemoradiotherapy showed longer survival than those receiving cisplatin and fluorouracil induction chemotherapy plus chemoradiotherapy.